Calsequestrin 2

Alternative Names

  • CASQ2
  • Calsequestrin, Fast-Twitch, Cardiac Muscle
Back to search Result
OMIM Number

114251

Gene Map Locus
1p13.1

Description

The CASQ2 gene encodes a calcium binding protein called calsequestrin 2 that stores calcium, which is vital for the functionality of muscles.  This protein is found in the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells.  Within myocytes, the calsequestrin 2 protein acts as a storage center for calcium ions in the sarcoplasmic reticulum; most of these ions bind by clusters of acidic residues at the protein surface.  The Calsequestrin 2 protein also regulates the release of lumenal Ca(2+) through the RYR2 channel; this plays an essential role in triggering muscle contractions including these involved in the heart rhythm.  Defects in this protein have been associated with catecholaminergic polymorphic ventricular tachycardia type 2, a disease characterized by adrenergically induced ventricular tachycardia (VT) that may lead to sudden death due to cardiac arrest.

Molecular Genetics

The CASQ2 gene is located on chromosome 1p13.1 and contains 11 exons spanning approximately 69 kb in the genomic DNA.  The encoded protein comprises 399 amino acids with a molecular weight of 46 kDa.  Thirteen mutations in the CASQ2 gene have been identified in patients with an autosomal recessive form of catecholaminergic polymorphic ventricular tachycardia.  

Epidemiology in the Arab World

View Map

Other Reports

Arab

Information to be added soon. 

Saudi Arabia

Al-Hassnan et al. (2013) described a consanguineous Saudi family with two siblings affected with catecholaminergic polymorphic ventricular tachycardia.  The proband had a history of exercise-induced syncope since he was 9 years of age.  At the age of 15 years, ectopic ventricular beats then nonsustaind then sustained polymorphic VT was observed on Holter monitor and treadmill exercise testing.  He was on Atenolol therapy; however, he had recurrence of syncope.  Subsequently, a transvenous single-chamber cardioverter defibrillator was implanted.  One year later, he had an appropriate implantable cardioverter defibrillator (ICD) shock.  His 8-year-old sister developed the same symptoms that were well controlled with Atenolol.  Using direct sequencing for the CASQ2 gene, a novel homozygous c.230 T>C missense mutation was found in both affected siblings.  This mutation resulted in a substitution of leucine to proline at position 77 (p.L77P).  The parents and the two unaffected siblings were heterozygous carriers. 

© CAGS 2024. All rights reserved.